These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23115404)

  • 1. Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study.
    Randall S; Roehrs TA; Roth T
    Sleep; 2012 Nov; 35(11):1551-7. PubMed ID: 23115404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
    Roehrs TA; Roth T
    J Clin Sleep Med; 2016 Mar; 12(3):319-25. PubMed ID: 26446253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
    JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study.
    Roehrs TA; Randall S; Harris E; Maan R; Roth T
    Sleep; 2011 Feb; 34(2):207-12. PubMed ID: 21286241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T; Krystal A; Steinberg FJ; Singh NN; Moline M
    Sleep; 2013 Feb; 36(2):189-96. PubMed ID: 23372266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.
    Roehrs TA; Randall S; Harris E; Maan R; Roth T
    J Psychopharmacol; 2012 Aug; 26(8):1088-95. PubMed ID: 22004689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD; Erman M; Zammit GK; Soubrane C; Roth T;
    Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
    Erman MK; Zammit G; Rubens R; Schaefer K; Wessel T; Amato D; Caron J; Walsh JK
    J Clin Sleep Med; 2008 Jun; 4(3):229-34. PubMed ID: 18595435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
    Perlis ML; McCall WV; Krystal AD; Walsh JK
    J Clin Psychiatry; 2004 Aug; 65(8):1128-37. PubMed ID: 15323600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
    Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
    Asnis GM; Chakraburtty A; DuBoff EA; Krystal A; Londborg PD; Rosenberg R; Roth-Schechter B; Scharf MB; Walsh JK
    J Clin Psychiatry; 1999 Oct; 60(10):668-76. PubMed ID: 10549683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial.
    Dockhorn RJ; Dockhorn DW
    Clin Neuropharmacol; 1996 Aug; 19(4):333-40. PubMed ID: 8828996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
    Black J; Pillar G; Hedner J; Polo O; Berkani O; Mangialaio S; Hmissi A; Zammit G; Hajak G
    Sleep Med; 2017 Aug; 36():86-94. PubMed ID: 28735928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.
    Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T
    Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
    Maroo N; Hazra A; Das T
    Indian J Pharmacol; 2013; 45(1):34-9. PubMed ID: 23543804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
    Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
    J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.
    Morin CM; Vallières A; Guay B; Ivers H; Savard J; Mérette C; Bastien C; Baillargeon L
    JAMA; 2009 May; 301(19):2005-15. PubMed ID: 19454639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
    Mayer G; Wang-Weigand S; Roth-Schechter B; Lehmann R; Staner C; Partinen M
    Sleep; 2009 Mar; 32(3):351-60. PubMed ID: 19294955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.